These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22787556)

  • 21. Exposure to a combination of MWCNTs and DBP causes splenic toxicity in mice.
    Zhou T; He Y; Qin Y; Wang B; Zhang H; Ding S
    Toxicology; 2022 Jan; 465():153057. PubMed ID: 34864091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinogenic susceptibility to N-bis(2-hydroxypropyl)nitrosamine (DHPN) in rasH2 mice.
    Okamura M; Moto M; Kashida Y; Machida N; Mitsumori K
    Toxicol Pathol; 2004; 32(4):474-81. PubMed ID: 15223773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of carbon nanotubes on lung and dermal cellular behaviors.
    Luanpitpong S; Wang L; Rojanasakul Y
    Nanomedicine (Lond); 2014 May; 9(6):895-912. PubMed ID: 24981653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity of carbon nanotubes to p21 and hus1 gene deficient mammalian cells.
    Tong L; Zhang W; Hang H; Yu Z; Chu PK; Xu A
    J Nanosci Nanotechnol; 2011 Dec; 11(12):11001-5. PubMed ID: 22409043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study for carcinogenicity of 7 different multi-wall carbon nanotubes with different physicochemical characteristics by a single intraperitoneal injection in male Fischer 344 rats.
    Sakamoto Y; Hojo M; Kosugi Y; Watanabe K; Hirose A; Inomata A; Suzuki T; Nakae D
    J Toxicol Sci; 2018; 43(10):587-600. PubMed ID: 30298847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proposal to Eliminate Urethane-Treated Positive Control Dose Groups in 26-Week Tg.rasH2 Carcinogenicity Studies.
    Paranjpe MG; Rudmann D; Sargeant A; Morse M; Yonpiam R; Bonnette K; Albretsen J; Papagiannis C
    Int J Toxicol; 2021; 40(3):207-210. PubMed ID: 33813924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidant defenses and histological changes in Carassius auratus after combined exposure to zinc and three multi-walled carbon nanotubes.
    Yan L; Feng M; Liu J; Wang L; Wang Z
    Ecotoxicol Environ Saf; 2016 Mar; 125():61-71. PubMed ID: 26655435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice.
    Takaoka M; Sehata S; Maejima T; Imai T; Torii M; Satoh H; Toyosawa K; Tanakamaru ZY; Adachi T; Hisada S; Ueda M; Ogasawara H; Matsumoto M; Kobayashi K; Mutai M; Usui T
    Toxicol Pathol; 2003; 31(2):191-9. PubMed ID: 12696579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans.
    Kuempel ED; Jaurand MC; Møller P; Morimoto Y; Kobayashi N; Pinkerton KE; Sargent LM; Vermeulen RC; Fubini B; Kane AB
    Crit Rev Toxicol; 2017 Jan; 47(1):1-58. PubMed ID: 27537422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbon nanotubes with high bone-tissue compatibility and bone-formation acceleration effects.
    Usui Y; Aoki K; Narita N; Murakami N; Nakamura I; Nakamura K; Ishigaki N; Yamazaki H; Horiuchi H; Kato H; Taruta S; Kim YA; Endo M; Saito N
    Small; 2008 Feb; 4(2):240-6. PubMed ID: 18205152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of susceptibility of transgenic mice carrying the human c-Ha-ras proto-oncogene (rasH2 mice) to phenolphthalein in a 6-month carcinogenicity study.
    Koujitani T; Yasuhara K; Usui T; Nomura T; Onodera H; Takagi H; Hirose M; Mitsumori K
    Cancer Lett; 2000 May; 152(2):211-6. PubMed ID: 10773414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biocompatibility and Carcinogenicity of Carbon Nanotubes as Biomaterials.
    Aoki K; Saito N
    Nanomaterials (Basel); 2020 Feb; 10(2):. PubMed ID: 32033249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible mechanism on enhanced carcinogenesis of genotoxic carcinogens and unsolved mechanisms on lesser carcinogenic susceptibility to some carcinogens in rasH2 mice.
    Mitsumori K
    J Toxicol Sci; 2003 Dec; 28(5):371-83. PubMed ID: 14746341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation on carcinogenicity of chemicals using transgenic mice.
    Mitsumori K
    Toxicology; 2002 Dec; 181-182():241-4. PubMed ID: 12505318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in the number of animals and the evaluation period for the positive control group in Tg.rasH2 short-term carcinogenicity studies.
    Shah SA; Paranjpe MG; Atkins PI; Zahalka EA
    Int J Toxicol; 2012; 31(5):423-9. PubMed ID: 22988008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary and pleural inflammation after intratracheal instillation of short single-walled and multi-walled carbon nanotubes.
    Fujita K; Fukuda M; Endoh S; Maru J; Kato H; Nakamura A; Shinohara N; Uchino K; Honda K
    Toxicol Lett; 2016 Aug; 257():23-37. PubMed ID: 27259835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbon nanotubes for biomaterials in contact with bone.
    Saito N; Usui Y; Aoki K; Narita N; Shimizu M; Ogiwara N; Nakamura K; Ishigaki N; Kato H; Taruta S; Endo M
    Curr Med Chem; 2008; 15(5):523-7. PubMed ID: 18289008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbon nanotubes: biomaterial applications.
    Saito N; Usui Y; Aoki K; Narita N; Shimizu M; Hara K; Ogiwara N; Nakamura K; Ishigaki N; Kato H; Taruta S; Endo M
    Chem Soc Rev; 2009 Jul; 38(7):1897-903. PubMed ID: 19551170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment and Validation of an Ultra-Short-Term Skin Carcinogenicity Bioassay Using Tg-rasH2 Mice.
    Kawabe M; Urano K; Suguro M; Hara T; Kageyama Y; Mera Y; Tsutsumi H
    Vet Pathol; 2020 Jan; 57(1):192-199. PubMed ID: 31221040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbon nanotubes elicit DNA damage and inflammatory response relative to their size and shape.
    Yamashita K; Yoshioka Y; Higashisaka K; Morishita Y; Yoshida T; Fujimura M; Kayamuro H; Nabeshi H; Yamashita T; Nagano K; Abe Y; Kamada H; Kawai Y; Mayumi T; Yoshikawa T; Itoh N; Tsunoda S; Tsutsumi Y
    Inflammation; 2010 Aug; 33(4):276-80. PubMed ID: 20174859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.